F-18 FDG PET/CT characterization of talc pleurodesis-induced pleural changes over time: A retrospective study

Clinical Nuclear Medicine

Volumn 34, Issue 12, 2009, Pages 886-890

  Nguyen, Nghi C ^a   Tran, Isaac ^a   Hueser, Christopher N ^b   Oliver, Dana ^a   Farghaly, Hussein R ^a   Osman, Medhat M ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

F 18 FDG PET CT; Pleural changes; Talc pleurodesis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TALC;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EVALUATION; COLON ADENOCARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG UPTAKE; FEMALE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MALE; MALIGNANT MESOTHELIOMA; MELANOMA; PLEURA DISEASE; PLEURA THICKENING; PLEURODESIS; RETROSPECTIVE STUDY;

DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION; PLEURAL NEOPLASMS; PLEURISY; PLEURODESIS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TALC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 74249088962     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181bece11     Document Type: Article

References (20)

1. Weissberg D, Ben-Zeev I. Talc pleurodesis: experience with 360 patients. J Thorac Cardiovasc Surg. 1993;106:689-695.
2. Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest. 1994;106:1215-1222.
3. Rodriguez-Panadero F, Antony VB. Pleurodesis: state of the art. Eur Respir J. 1997;10:1648-1654. (Pubitemid 27311086)
4. Kroegel C, Antony VB. Immunobiology of pleural inflammation: Potential implications for pathogenesis, diagnosis, and therapy. Eur Respir J. 1997;10: 2411-2418.
5. Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: Additional value for diagnostic imaging and patient management. J Nucl Med. 2003;44:1200-1209.
6. Townsend DW, Beyer T. A combined PET/CT scanner: The path to true image fusion. Br J Radiol. 2002;75:S24-S30.
7. Kwek BH, Aquino SL, Fischman AJ. Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis. Chest. 2004;125:2356-2360.
8. Weiss N, Solomon SB. Talc pleurodesis mimics pleural metastases. Differentiation with positron emission tomography/computed tomography. Clin Nucl Med. 2003;28:811-814.
9. Al-Sarraf N, Doddakula K, Wedde T, et al. Positron emission tomography staging of pleural deposits following Monaldi's procedure: An accurate reflection or a false staging? Interact CardioVasc Thorac Surg. 2007;6:260-261.
10. Browne J, De Pierro A. A row-action alternative to the EM algorithm for maximizing likelihoods in emission tomography. IEEE Trans Med Imaging. 1996;15:687-699.
11. Strange C, Tomlinson JR, Wilson C, et al. The history of experimental pleural injury with tetracycline, empyema, and carrageenan. Exp Mol Pathol. 1989; 51:205-219.
12. Antony VB, Rothfuss KJ, Godbey SW, et al. Mechanism of tertacyclinehydrochloride- induced pleurodesis. Tertacycline-hydrochloride- stimulated mesothelial cells produce a growth-factor like activity for fibroblasts. Am Rev Respir Dis. 1992;146:1009-1013.
13. Nguyen M, Varma V, Perez R, et al. CT with histopathologic correlation of FDG uptake in a patient with pulmonary granuloma and pleural plaque caused by remote talc pleurodesis. Am J Roentgenol. 2004;182:92-94.
14. Williams T, Gostelow B, Woods D, et al. Apical pleural mass developing following talc pleurodesis. Respir Med. 1998;92:358-359.
15. Avila NA, Dwyer AJ, Rabel A, et al. CT of pleural abnormalities in lymphangioleiomyomatosis and comparison of pleural findings after different types of pleurodesis. Am J Roentgenol. 2006;186:1007-1012.
16. Murray JG, Erasmus JJ, Bahtiarian EA, et al. Talc pleurodesis simulating pleural metastases on 18F-fluorodeoxyglucose positron emission tomography. Am J Roentgenol. 1997;168:359-360.
17. Leung AN, Mueller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. Am J Roentgenol. 1990;154:487-492.
18. Westerterp M, Pruim J, Oyen W, et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging. 2007;34:392-404.
19. Blake MA, Slattery JM, Kalra MK, et al. Adrenal lesions: Characterization with fused PET/CT image in patients with proved or suspected malignancyinitial experience. Radiology. 2006;238:970-977.
20. Kim SK, Allen-Auerbach M, Goldin J, et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med. 2007;48:214-220.